Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resection

INTRODUCTION: Malignant primary brain tumors are one of the most aggressive cancers. Pretreatment serum nonneuronal biomarkers closely associated with postoperative outcomes are of high clinical relevance. The present study aimed to identify potential pretreatment serum biomarkers that may influence...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Chung-Chih, Lee, Tzong-Shiun, Tsuang, Fon-Yih, Lin, Pei-Lin, Cheng, Ya-Jung, Cheng, Hsiao-Liang, Wu, Chun-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609955/
https://www.ncbi.nlm.nih.gov/pubmed/28969023
http://dx.doi.org/10.18632/oncotarget.18891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609955/
https://www.ncbi.nlm.nih.gov/pubmed/28969023
http://dx.doi.org/10.18632/oncotarget.18891

Ejemplares similares